October 24, 2025 a 12:38 pm
ZTS: Analysts Ratings - Zoetis Inc.
The stock of Zoetis Inc., known for its comprehensive range of animal health products, presents a stable outlook with consistent interest from analysts. With a robust presence across livestock and companion animal segments, the company's innovative solutions cater to a global demand. Analyst ratings depict a favorable sentiment with a strong buy and buy recommendations maintaining significant proportion. The absence of sell or strong sell recommendations reflects strong market confidence.
Historical Stock Grades
| Recommendation | Count | Score |
|---|---|---|
| Strong Buy | 5 | |
| Buy | 8 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment around Zoetis Inc. has remained relatively stable over the recent months. Ratings have consistently shown a strong preference towards 'Buy', highlighting market confidence. Notably, the number of 'Hold' recommendations have seen a slight increase towards mid-2025, which might indicate growing caution. Key trends include:
- Consistent analyst interest with little variation in total ratings.
- Strong Buy ratings have remained stable, reflecting continued confidence.
- Hold ratings have seen minor fluctuations, suggesting slight caution.
Percentage Trends
Zoetis Inc. has experienced stable analyst ratings over the past months with minor shifts. The occurrence of Buy recommendations has dominated, yet the weightage of Hold ratings has marginally increased. Notable shifts include:
- From October 2024 to October 2025, Strong Buy ratings shifted from 7 to 5, observed by a similar decrease in Buy ratings.
- A slight increase in Hold recommendations from early 2024 indicates growing cautious sentiment.
- No Sell or Strong Sell recommendations have been recorded recently.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-20 | Neutral | Neutral | UBS |
| 2025-09-09 | Buy | Buy | Argus Research |
| 2025-08-11 | Overweight | Overweight | Piper Sandler |
| 2025-07-17 | Market Perform | Outperform | Leerink Partners |
| 2025-06-18 | Hold | Buy | Stifel |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-17 | Market Perform | Outperform | Leerink Partners |
| 2025-06-18 | Hold | Buy | Stifel |
| 2021-07-16 | Market Perform | Outperform | Raymond James |
| 2021-07-15 | Market Perform | Outperform | Raymond James |
| 2021-03-08 | Buy | Neutral | B of A Securities |
Interpretation
From the recent analyst sentiment, Zoetis Inc. seems to maintain a robust position in the market. Most ratings indicate a continuity of confidence without significant negative sentiment. The incremental increase in Hold ratings suggests a cautious optimism, or perhaps a hedging of risk given market dynamics. Overall, there is no substantial shift towards pessimism, indicating stable investor confidence in Zoetis's business outlook.
Conclusion
Zoetis Inc. remains on solid footing with analysts maintaining favorable ratings. The company's wide-ranging product offerings solidify its market position in animal health sectors, creating potential resilience against market volatilities. While recent trends show slight shifts towards more cautious ratings, the core sentiment remains positive. Recommendations continue to support a buy stance, reflecting confidence in the company's strategic direction and growth potential.